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Abstract
We show that IL-36α induced maturation of human MDDCs and stimulated 
differentiation of IFN-γ producing (Type 1) CD3+ lymphocytes but was not as 
effective as IL-36β in doing so. For the first time, we also show that IL-36α induced 
expression of CD14 by MDDCs and this was highly potentiated by co-cultured with
IFN-γ. In contrast, lipopolysaccharide (LPS) did not increase CD14 expression by 
MDDCs, suggesting that if MDDCs represent a physiologically relevant population in
vivo, they need to be stimulated by relevant inflammatory cytokines prior to CD14
expression and detection of LPS, expressed by Gram negative bacteria. IFN-γ  
synergised with IL-36α to restore the high levels of CD11c expression by MDDCs, 
which was reduced by culture with these cytokines in isolation. IL-36α / IFN-γ 
synergy also correlated with increased binding of the opsonic complement protein
(iC3b) to MDDCs. However although IL-36α increased the phagocytic capacity of 
MDDCs for Salmonella Typhimurium 4/74 this was not synergistically increased by
IFN-γ (p > 0.05).  
In conclusion we report the hitherto unknown effects of IL-36α on the innate cell 
function of human MDDCs.
Introduction
In the past decade, new members of the IL-1 family of cytokines have been described
but there is still very little data reported on their biological effects and virtually
nothing is known about these cytokines in the context of the human immune system.
Recently it has been shown that human monocyte derived dendritic cells (MDDCs)
mature when stimulated with novel IL-1 cytokines (IL-36β or IL-36γ) and that IL-
36β-matured MDDCs induce differentiation of T helper (type 1) (Th1) lymphocytes 
[1].  However, it is not known whether IL-36α, which also signals via the same 
receptor (IL-36R), has the same effect on maturation. Furthermore, nothing has been
reported regarding the effect of novel IL-1 cytokines in conjunction with other DC
maturation signals such as IFN-γ. IFN-γ is known to increase the expression of 
maturation markers, such as CD80, CD86, CD83 and HLA-DR, on the surface of
MDDCs [2, 3], while other studies have shown that MDDC maturation is also
associated with increased expression of HLA-DR [4] and CD83 [5] and decreased
expression of CD1a [6]. IFN-γ is also known to potentiate the maturation of MDDCs 
by IL-1β [2] but it is not known whether IFN-γ potentiates maturation of MDDCs by 
novel IL-1 cytokines.
Another important function of IFN-γ is in clearing pathogenic bacteria, such as 
salmonella, and in this case the highest concentration of IFN-γ is produced by Th1 
lymphocytes which enter intestinal tissue from the blood [7]. IFN-γ produced by these 
cells activates innate immune cells by increasing phagocytosis and upregulating
cellular killing pathways [8-11]. Therefore, the induction of Th1 cells by novel IL-1
cytokines may have an effect on bacterial immunity, while it has also been reported
that culture of TLR4 expressing MDDCs with IFN-γ also induces production of IL-12 
and IL-27 which makes lymphocytes more receptive to IL-12 [3].  Thus, IFN-γ may 
have a bi-directional effect on the activation of DCs and Th1 lymphocytes and it is
possible that this may be affected by novel IL-1 cytokines, which induce Th1
proliferation, via DC maturation.
There is some evidence to suggest that MDDCs do represent a physiological
population which replenish resident tissue DCs following infection [12-13]. However,
differentiation of monocytes to MDDCs is associated with loss of CD14 expression
and an increase in CD11c is increased. These are contradictory effects since both are
important in the recognition of Gram negative bacteria. The important role of CD14 in
LPS recognition by innate immune cells has been known for a number of years
[reviewed 14], while CD11c increases phagocytosis of iC3b-opsonized particles [15]
and has been shown to induce LPS responsiveness [16]. However, nothing has been
reported on the effect of IFN-γ on CD14 and CD11c expression by MDDCs matured 
with novel IL-1 cytokines and it is possible that these MDDCs remain responsive to
Gram negative bacteria (by maintaining CD14 expression) when stimulated with IFN-
γ, or other cytokines which are produced during infection. 
The aims of the study we report were; (1) to determine whether IL-36α increased  
maturation of MDDCS. (2) To determine whether IFN-γ synergised with IL-36α to 
induce maturation of MDDCs (as is the case with IL-1β). (3) Determine how these 
events may influence expression of CD14 and CD11c, which are important in
detecting gram negative bacteria.
Materials and Methods
Reagents
Unless otherwise stated all laboratory reagents were purchased from Sigma, Poole,
UK and all antibodies were purchased from Serotec, Oxford, UK. Recombinant
human IL-36α and IL-36β proteins, and murine anti-human IL-36R were supplied by 
the Amgen, Corporation, Seattle, Washington, USA.
Bioethics
All studies were conducted following approval by local ethics committees.
Endotoxin assays
A kinetic chromogenic LAL assay (Lonza, USA) was performed by a verified
technician prior to shipment of IL-1 reagents by Amgen. Assay sensitivity is between
0.005-50.0 EU/ml. Results showed LPS concentrations of < 0.209, which are
equivalent to << 0.01 pg/ml in 100 ng IL-1 protein, were used in cell culture. Similar
results were obtained at Nottingham prior to use. As an additional test for LPS
contamination we used a THP 1 sensitivity assay which showed that the cells did not
produce TNFα in response to IL-1 reagents but did produce TNFα when stimulated 
with bacterial lipopolysaccharide (data not shown).
FACS analyses
FACS analyses were performed by standard methods. Briefly, 1 x 106 test cells per
group resuspended in FACS buffer (BSA (1 % w/v); EDTA (2 mM). The cells were
blocked in FACS buffer containing human serum (10 % v/v) for 15 min prior to
incubation for 45 min with relevant antibodies (see table 1). Cells were then analysed
using a FACSCanto II analyser (Becton Dickinson, USA). Samples were acquired
using CellQuest pro software (Becton Dickinson, USA) and analysed using WinMDI
2.8 software.  Cell viability was assessed by propidium iodide uptake (20 μg/ml for 10 
min) via FACS analysis and was found to be > 90% in all cases.
Differentiation and culture of monocyte derived dendritic cells (MDDCs)
Blood products from healthy donors were obtained from the National blood
transfusion service (Sheffield, UK). Isolation of peripheral blood monocytes (PBMs)
was performed using differential centrifugation in histopaque 1077 by standard
methods. Briefly, 106 cells/ml were cultured in 6 well plates containing supplemented
RPMI media (see above) with additional GM-CSF (50 ng/ml) and IL-4 (10 ng/ml) for
5 days.
Analysis of MDDC phenotype and maturation status.
Expression of CD1a, CD11c, CD14 and HLA-DR were measured by
FACS analyses (as previously stated). The phenotype of these cultured cells was
CD11chigh, CD1ahigh, HLA-DRhigh, and CD14low, consistent with their differentiation
to immature MDDCs.
FACS analysis of maturation status following culture of MDDC with IL-36α, IL-
36β and IFN-γ. 
To assess IL-36α-dependant maturation of MDDCs, changes in HLA-DR, CD1.a, 
CD40, CD80, CD83 and CD86 expression were assessed by FACS analysis on the
surface of day 5 (Immature) MDDCs which had been washed 3 times in PBS prior to
incubation with IL-36α (500 ng/ml) for 48h. Expression of these maturation markers 
was then compared with expression of these markers on the surface of unstimulated
day 5 MDDCs which were washed and cultured in media only for a further 48 or, as
an additional control, MDDCs incubated with relevant isotype controls.
In a separate series of experiments, maturation of MDDCs, following culture with IL-
36α or IL-36β (500 ng/ml), was compared with maturation following culture with  
IFN-γ (100 ng/ml) or following co-culture with IL-1 cytokine and IFN-γ. In other 
experiments, MDDCs were cultured with S. Typhimurium LPS (100 ng/ml).
T lymphocyte proliferation assays
Following maturation of MDDCs with IL-36α, the MDDCs were co-cultured with 
allogeneic CD3+ lymphocytes at a ratio of 1:50 for 96h.
T cell proliferation was measured after 96h using CellTiter 96 AQueous One Solution
Cell Proliferation Assay (Promega, Madison, USA) according to manufacturers
instructions. Values were compared to those obtained from a standard curve with a
maximum value of 1 x 106 CD3+ lymphocytes. As a positive control CD3+
lymphocytes were cultured for 96h in media containing Concanavalin A (10 g/ml).
Further comparison was made between IL-36α-matured MDDCs and MDDCs 
matured with IL-36β (500 ng/ml) and IL-1β (100 ng/ml)) prior to proliferation 
analysis and as a negative control CD3+ lymphocytes were cultured for 96h in media
containing no additional supplements. All samples were cultured in triplicate and
repeated on 3 separate occasions.
Determination of the cytokine profile of IL-36α-matured MDDCs and T 
lymphocytes stimulated with IL-36α -matured MDDCs 
Immature MDDCs were stimulated with IL-36α (500 ng/ml) or IL-1F2 (10 ng/ml or 
100 ng/ml) for 48h. After 48h, a standard ELISA analysis was used to measure IL-12
p70 and IL-18 in the MDDC supernatants. As a negative control, cell supernatants
were obtained from immature (day 5) MDDCs which had been washed and cultured
for 48h in media containing no supplements. As a positive control (and to provide
comparative data) the affect of IL-36β (500 ng/ml) or IL-1 β (100 ng/ml) on IL-12 
and IL-18 production was also measured. To determine T cell phenotypes
differentiated by IL-1-matured MDDCs, analysis of IL-10 and IFN-γ concentrations 
were performed using standard ELISA analyses in supernatants obtained after 96h co-
culture of MDDCs with CD3+ lymphocytes (as stated above).
Measurement of the phagocytic capacity of MDDC cultured with or without
cytokine.
S. Typhimurium strain 4/74 was cultured to mid-log phase prior to counting colony
forming units (CFU) and assessment of growth. When required for use, Salmonella
were diluted to give a multiplicity of infection (MOI) of 10 prior to co-culturing with
day 6 MDDC, day 5 MDDC cultured with IL-36α (500 ng/ml) for 48h prior to the 
addition of Salmonella or day 5 MDDC cultured with IL-36α (500 ng/ml) and IFN-γ 
(100 ng/ml) for 24h prior to the addition of Salmonella. After 2h culture, the MDDCs
were washed 3 times by centrifugation in PBS and then lysed using Triton x-100
(0.5% v/v) (Sigma). Salmonella CFU were then counted in lysed cells. Each
experiment was performed in quadruplicate on 3 separate occasions.
Measurement of iC3b binding to IL-36α stimulated MDDCs 
Day 5 MDDCs, which had been incubated with IL-36α (500 ng/ml), IFN-γ (100 
ng/ml) or co-cultured with IL-36α and IFN-γ, for 48h were washed 3 times in PBS. 
The cells were incubated for 30 min with 2.5 UG human iC3b protein (Calbiochem,
Nottingham UK), washed 3 times in PBS and then incubated with
mouse anti-human ic3b (neoantigen) (1 μg )  (monoclonal antibody IgG2b anti human 
iC3b (neoantigen) conjugated to APC, for 30 min at 4 0C. The cells were then washed
3 times in PBS prior to FACS analyses.
RNA extraction
RNA extraction (using RNeasy mini kits) and DNase digestions were performed
using standard procedures recommended by the kit manufacturer (Qiagen, Crawley,
UK). The concentration of RNA was determined using a Nanodrop (ND1000)
spectrophotometer (NanoDrop technologies, Wilmington, DE, USA) according to the
manufacturer’s instructions. A260/A280 ratio greater than 1.8 was considered to be
pure. Reverse transcription was performed using a Transcriptor First Strand cDNA
Synthesis Kit (Roche, West Sussex, UK) according to manufacturers instructions.
Measurement of IL-36R mRNA expression by quantitative PCR
RNA was extracted from blood monocytes, MDDCs and HT29 (IL-36R positive
control) cells prior to measurement of IL-36R expression. Gene-specific primers and
probes were designed using the Roche Universal Probe Library (UPL) Assay Design
Centre software. To allow differentiation of the amplified cDNA from contaminating
genomic DNA, intron-spanning primers (primers that annealed to exon sequences on
both sides of an intron or on exon/exon boundaries) were designed (Roche
Diagnostics Corporation, 2007). The LightCycler® 480 Probes Master Kit (Roche,
Burgess Hill, West Sussex UK) was used for qRT-PCR and the manufacturer’s
guidelines for use with LightCycler® 480 Multiwell Plate 96 were followed. Gene-
specific primers were obtained from Invitrogen, (Paisley, UK) via Fisher Scientific
(Loughborough, UK) and 5-carboxyfluorescein (FAM)-labelled probes were obtained
from Roche Diagnostics.
The following forward and reverse IL-36R primer sequences were used:
Forward: GCTGGAGTGTCCACAGCATA
Reverse: GCGATAAGCCCTCCTATCAA
Genbank accession number AF284454, UPL number 24.
Expression of a house keeping gene (Glyceraldehyde-3-phosphate dehydrogenase)
(GAPDH) was used as a reference comparison.
Forward: CTCTGCTCCTCCTGTTCGAC
Reverse: ACGACCAAATCCGTTGACTC
The PCR cycling program used was as follows: Pre-incubation (1 cycle; 95oC for 10
minutes), Amplification (45 cycles; 95oC for 10 seconds, 60oC for 40 seconds and
72oC for 1 second) and Cooling (1 cycle; 40oC for 10 seconds). All experiments were
performed in triplicate and PCR product was assessed using standard acrylamide gels.
A relative quantification method based on the relative changes in mRNA expression
of the target gene versus changes in mRNA expression of GAPDH was used to
quantify IL-36R expression. Relative expression of the target gene to the reference
gene (calibrator given the arbitrary unit of 1) was calculated using the LC480
software program (Roche). The Advanced Relative quantification efficiency corrected
calculation model was used according to LC 480 user manual (Roche). PCR product
was also eluted by gel electrophoresis and was shown to be of the expected amplicon
size of 80 base pairs (data not shown). The human colonic carcinoma cell line HT29
(a kind gift from Professor Susan Watson, University of Nottingham) was used as a
positive control of IL-36R expression and human monocytic THP-1 cells (purchased
from the European collection of cell cultures (Salisbury, Wilts UK), were used as a
calibrator (negative control) as previously published (1).
Statistical Analysis
An analysis of variance (ANOVA) test with a one-way classification was used to
calculate significant differences (P < 0.05), between test and control samples
following cytokine ELISA analyses and the difference between the number of cells,
within total cell populations, expressing CD1a or HLA-DR following stimulation with
IL-1 cytokines and IFN-γ.  Tukey’s test was used post hoc to determine significance 
between individual means. Minitab software was used for all statistical analyses. To
statistically analyse the effect of cytokine on the phagocytosis of Salmonella, a
students t-test was performed to compare Salmonella numbers in IL-36α cultured 
MDDCs with untreated MDDCs or MDDCs cultured with both IL-36α and IFN-γ 
with untreated MDDCs. Statistical analysis was performed using Mintab software
licensed to Nottingham University.
Results
IL-36α induces maturation of human MDDCs  
We investigated whether, or not, IL-36α induced MDDC maturation, as previously 
shown with IL-36β and IL-36γ. In comparison with isotype controls (Fig 1A),
expression of both HLA-DR and CD1a was increased on the surface of immature
MDDCs (monocytes cultured for 5 days with GM CSF/IL-4) and cultured for 48h in
culture media without cytokines (Fig 1B). A distinct population of CD1a high/HLA-
DRmed MDDCs (which represented > 70% of the total population in all replicates) was
gated as (R1) for comparison with the same population following cytokine treatment.
When immature MDDCs were cultured with IL-36α for 48h CD1a expression
decreased and HLA-DR expression was increased, with the R1 population
representing < 40 % of the total MDDC population in all replicate experiments (Fig
1C). As an additional marker of MDDC maturation, CD83 was measured on the
surface of all control and test samples. Our data shows that CD83 expression was
increased on the surface of MDDCs cultured with IL-36α for 48h compared to
MDDCs which had been cultured without cytokine for the same time period (Fig 1D).
IL-36 α induces expression of CD40 but not CD80 or CD86 on the surface of 
MDDCs.
We investigated the expression of essential co-stimulatory molecules, required for full
activation of cognate lymphocytes, by MDDCs cultured with IL-36α. Following 
incubation of immature MDDCs with IL-36α (500 ng/ml) for 48h.  Our data showed 
that IL-36α increased expression of CD40, compared to either unstimulated MDDCs 
or isotype controls (Fig 2A).  However, IL-36α had no effect on either CD80/CD86 
expression (Fig 2A) or CD86, which remained at levels expressed by unstimulated
MDDCs.
IL-36α stimulates production of pro-inflammatory cytokines (IL-12p70 and IL-
18 from human MDDCs
We next investigated whether production of IL-12p70 and/or IL-18 from immature
(day 5) MDDCs was stimulated following culture with IL-36α for 48h. We compared 
our results to MDDCs cultured with IL-36 β or IL-1β for the same time period, both 
of which are known to stimulate IL-12p70 and IL-18. Our results show that IL-36α 
stimulated a significant increase (P < 0.05) in IL-12p70 compared to IL-12p70
concentrations measured in the supernatants isolated from unstimulated MDDCs (Fig
3A). However, IL-12p70 concentrations induced by IL-36α were lower than those 
induced by either IL-36 β or IL-1β but this difference was not significant (P > 0.05)
(Fig 3A). IL-36α (and IL-36 β or IL-1β) also stimulated a significant increase in IL-18 
production when cultured with immature MDDCs for 48h (Fig 3B). The concentration
of IL-18 induced by IL-36 β was, again, lower than IL-18 production  stimulated by 
either IL-36 β or IL-1β and in the latter case the difference was significant (P < 0.05) 
(Fig 3B).
IL-36α -matured MDDCs induce proliferation of Th1 lymphocytes in allogeneic 
MDDC/CD3+ lymphocyte cultures
MDDCs, which had been matured by culture with IL-36α for 48h, were cultured for 5 
days with allogeneic CD3+ lymphocytes to determine whether they increased
lymphocyte proliferation and skewed the phenotypic characteristic towards Th1 (pro-
inflammatory), as is the case with IL-1β and IL-36β, or Th2 (anti-inflammatory). Our 
results showed that IL-36α induced a > 2 fold increase in CD3+ numbers compared to 
the number of CD3+ lymphocytes cultured for 5 days without MDDCs (Fig 6A).
When the effect of IL-36α-matured MDDCs on lymphocyte proliferation was 
compared to positive controls, IL-36α maturation induced a comparative response to 
con A (> 2 fold increase) but a lesser effect when compared to either IL-36β or IL-1β 
(> 3 fold) (Fig 4A). IL-36α -matured MDDCs also stimulated a significant increase (P
< 0.05) in IFN-γ concentration in the supernatants isolated from allogeneic 
MDDC/CD3+ lymphocyte cultures but this was also significantly lower (P < 0.05)
than IFN-γ concentrations induced by either IL-36β or IL-1β-matured MDDCs  (Fig 
4B). IL-10 concentration in supernatants isolated from allogenic cultures was slightly
raised (~ pg/ml) when MDDCs were matured by IL-36α, IL-36β or IL-1β but this was 
not significant (P < 0.05) (Fig 4C).
IL-36α and IL-36β induces CD14 expression by human MDDCs and synergise
with IFN-γ to produce a CD14high/CD11chigh MDDCs phenotype
FACS analyses were used to measure expression of CD14 and CD11c on the surface
of immature MDDCs cultured with IL-1 cytokines and/or IFN-γ for 48h and these 
were compared to relevant isotype controls (Fig 5A). Although this study was
primarily about IL-36α, nothing has been published regarding the affect of IL-36β on 
these important innate immune molecules. Our data showed that
monocytes expressed a characteristic CD14high/CD11clow phenotype (Fig 5B) and
when these were differentiated into MDDC following 5 days of culture with GM CSF
and IL-4 the phenotype shifted to the characteristic phenotype of MDDCs,
CD14low/CD11chigh (Fig 5C). We then stimulated MDDCs with LPS for 48h and this
had no effect on relative CD14 or CD11c expression (Fig 5D). However, when
MDDC were cultured with either IFN-γ (Fig 5D); IL-36α (Fig 5E) or IL-36β (Fig 5F) 
the phenotype shifted towards increased CD14 expression and decreased expression
of CD11c. Our next series of experiments investigated whether IL-36α or IL-36β 
synergised with IFN-γ to affect expression of CD14 and CD11c. We show that there 
was a clear increase in CD14 expression and a return to high CD11c when MDDCs
were co-cultured for 48h with IL-36α and IFN-γ (Fig 5G) or IL-36β and IFN-γ (Fig 
5I).
IL-36α and IFN-γ synergistically increases binding of iC3b on the surface of 
MDDCs but not phagocytosis of Gram negative bacteria (Salmonella
Typhimurium)
Since CD 11c binds iC3b to the surface of cells, and CD11c expression was
synergistically increased on the surface of MDDCs cultured with both IL-36α and 
IFN-γ, we investigated whether, or not, this also lead to synergistic increases in 
binding of iC3b on the surfaced of MDDCs. The synergistic effect of IL-36α and IFN-
γ was measured by increased interaction of iC3b (an opsonin which binds to CD11c) 
on the surface of MDDCs when compared to either cytokines alone, although both
cytokines increased iC3b interaction in comparison to unstimulated MDDCs (Fig 6A).
However, our data shows that although IL-36α stimulated MDDCs phagocytosed 
more bacteria than unstimulated (age matched) MDDCs the increase was not
significant (P >0.05) but was significant (P <0.05) if MDDCs were cultured with both
IL-36α and IFN-γ (Fig 8B). When MDDCs were stimulated with IFN-γ only, the 
number of bacteria phagocytosed increased still further (compared with co-culture of
MDDCs with IL-36α and IFN-γ) but this increase was not significant (Fig 6B) 
IL-36α and IFN-γ stimulate similar levels of CD1a and CD83 expression by 
MDDCs but IL-36α is less potent in inducing HLA-DR 
To test whether any synergistic effects attributed to stimulation of MDDCs with both
IL-36α and IFN-γ were simply due to increased MDDC maturation, we measured 
expression of CD1a, CD83 and HLA-DR on the surface of immature MDDCs which
had been subsequently cultured with IL-36α or IFN-γ or co-cultured with IL-36α and 
IFN-γ for 48h. When MDDCs were cultured with IL-36α or IFN-γ or co-cultured with 
IL-36α and IFN-γ for 48h, expression of CD1a (Fig 7A) and CD83 (Fig 7B) was 
comparable and all were above isotype control levels. However, when HLA-DR
expression by MDDCs was measured following these treatments, IL-36α induced less 
expression than was measured for IFN-γ, which itself induced a similar level of HLA-
DR expression measured when MDDCs were co-cultured with IL-36α and IFN-γ (Fig 
7C).
Discussion
Our results show that IL-36α induces maturation of human MDDCs, as measured by 
increased expression of CD83 and HLA-DR and decreased expression of CD1a. IL-
36α also stimulated IL-12p70 and IL-18 production from MDDCs and the 
differentiation of (IFN-γ-producing) Th1 lymphocytes in allogeneic MDDC/CD3+ 
lymphocyte cultures. This effect has previously been shown for IL-36β and IL-36γ 
[1], although our results indicate that IL-36α is less potent than IL-36β in this regard.  
These results are also in accordance with a recent murine study which reported that
IL-36β induced the expression of maturation markers on the surface of bone marrow 
derived dendritic cells (BMDDC) and promotes Th1 proliferation in vitro and in vivo
[17]. However, our study also shows that IL-36α has a differential effect on the 
expression of co-stimulatory molecules, having no effect on CD80 or CD86
expression but increasing CD40 expression. This is different to the previously
reported effect of IL-36 β which induces both CD40 and CD80 expression on the 
surface of human MDDCs [1] and probably also reflect the reduced effect of IL-36α 
compared to IL-36β. It could also be the case that IL-36α and IL-36β differentially 
effect the production of IL-36RA, which although not tested here is an inhibitor of
both cytokines via IL-36R. However, IL-36α did not increase the effect of IFN-γ on 
the expression of standard maturation markers such as HLA-DR, CD83 or CD1a and
generally IL-36α only weakly induced HLA-DR expression, when compared to IFN-
γ.  However, these results may also show a different effect of the novel IL-1 cytokines 
when compared to IL-1β since a previous study has shown that both IL-1β and IFN-γ 
induce maturation of human MDDC and that these 2 cytokines synergise to increase
this effect [2].
The immune response to Gram negative bacteria requires not only the induction of
Th1 responses by APCs but also, initially, that the APCS can detect the presence of
the bacteria.  We therefore investigated the effect of IL-36α on CD14 expression and 
whether any additional affect on expression was provided by IFN-γ, which is an 
important cytokine in response to Gram negative bacteria. CD14 is an essential
component in the detection of bacterial LPS [18] and CD14 gene knock-out mice are
resistant to endotoxaemia induced by LPS injection [19]. Furthermore, LPS binding
of CD14 decreases its spatial proximity to Toll-like receptor 4 (TLR4) and it is via
TLR4 that the intracellular signalling cascade, which results in the production of pro-
inflammatory cytokines, is initiated [20]. More recently it has been reported that
CD14 also augments murine TLR4 endocytosis by dendritic cells, induced by LPS
[21]. Our results showed that both IL-36α and IFN-γ upregulated expression of CD14, 
when compared with unstimulated MDDCs, whereas LPS was unable to do so.
Previous studies have shown that LPS upregulates CD14 expression by human
monocytes, which were also stimulated for 48h [22]. However, when MDDCs were
cultured with IL-36α and IFN-γ, CD14 expression on the surface of MDDCs 
increased even further. Thus, IFN-γ synergises with IL-36α to induce high levels of 
CD14 expression by human MDDCs. Therefore CD14 expression, which is lost when
monocytes differentiate into MDDCs, is replenished when MDDCs are cultured with
IL-36α and this effect of IL-36α is synergistically enhanced by IFN-γ. 
We also investigated whether, or not, these cytokines affected expression of CD11c.
CD11c is a receptor for iC3b, which opsonizes micro-organisms to increase
phagocytosis [15], while transfection of CD11c genes into CHO cells has been shown
to induce LPS responsiveness [16]. Thus, expression of both CD11c and CD14 are
required for the efficient detection and phagocytosis of Gram negative bacteria such
as Salmonella. Furthermore, when CD11c is blocked on the surface of Langerhans
cells, proliferation of allogeneic T lymphocytes is prevented [23], which suggests that
CD11c is a vital molecule in the induction of adaptive immunity (atleast allogeneic
response) by DCs. As monocytes differentiate into (immature) MDDC, CD11c is
expressed on their cell membrane but our results showed that when immature MDDCs
were cultured with IL-36α, IL-36β or IFN-γ, expression of CD11c was supressed, 
while culture of MDDCs with LPS had no effect on CD11c. This latter result is in
accordance with a recent study which has reported that LPS down-regulates
expression of CD11c by murine splenic DCs and BMDCs but fails to do so in human
MDDCs [24]. However, when we cultured MDDCs with either IL-36α and IFN-γ or 
IL-36β and IFN-γ, the expression of CD11c was restored to the high levels expressed 
by immature (unstimulated) MDDCs. In accordance with these results, we also found
that IL-36α and IFN-γ synergised to increase binding of iC3b. The role of CD11c in 
bacterial uptake by human MDDCs is, however, complex since one study has shown
that blockade of CD11c has little effect on uptake of opsonized yeast particles and in
this study CD11b appeared to be the most dominant complement receptor [25]. In
contrast, Ben Nasr et al., (2006) [26] have previously reported that uptake of the
Gram negative bacteria Francisella tularensis is dependent on both CD11c and
CD11b. In our study we show that although increased CD11c expression due to IL-
36α/IFN-γ synergy was also associated with increased iC3b binding to MDDCs this 
was not fully correlated with Salmonella uptake. Our results showed that although
IL-36 α increased S. Typhimurium uptake by MDDCs and that this was increased to
significant levels when MDDCs were cultured with IL-36 α and IFN-γ, neither of 
these treatments increased uptake above that measured when MDDCs were incubated
with IFN-γ alone. We did not study the effect of IL-36α on CD11b expression (as 
investigated in previous studies mentioned above) and so it is possible that although
IL-36α increased CD11c expression and subsequent iC3b binding to MDDCs, CD11b 
may have a more dominant role in phagocytosis of S. Typhimurium. Some studies
have indicated that MDDCs are a physiological DC population generated in vivo
during inflammation (12-13), possibly serving to replenish spent peripheral DC
populations. If this is the case, then our study also suggests that they require
additional signals, not only provided by IL-36α alone but also other cytokines such as 
IFN-γ.   
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Figure Legends
Figure 1. IL-36α induces maturation of human MDDCs
Immature MDDCs (day 5) were cultured in media alone or in media containing IL-
36α (500 ng/ml) for 48h. After 48h FACS analyses were performed to measure 
surface expression of HLDR, CD83 and CD1a. FACS density plots were used to
analyse HLA-DR and CD1a expression in treated and untreated MDDCs. (A) Shows
isotype control IgG3.PE/IgG2a.FITC; (B) Gated population (R1) set according to the
distinct CD1a high/HLA-DRmed popluation observed in day 5 MDDCs washed and
cultured for 48h without further cytokine stimulation (>70% of all cells). (C) Shows a
shift in gated R1 population from CD1a high/HLA-DRmed (< 40% of cells) to
CD1amed/low/HLA-DRhigh when day 5 MDDCs are cultured with IL-36α for 48h. (D) 
shows that IL-36α increases CD83 expression on the surface of MDDCs above that 
measured in unstimulated MDDCs, cultured over the same time period (7 days).
FACS data shown are representative of data obtained on 5 separate occasions.
Figure 2. IL-36α differentially effects expression of co-stimulatory molecules on
the surface of MDDCs
Immature MDDCs (day 5) were cultured in media alone or in media containing IL-
36α (500 ng/ml) for 48h. After 48h FACS analyses were performed to measure 
surface expression of CD80, CD86 and CD40.
IL-36α did not increase expression of CD80 (A) or CD86 (B) above that measured in 
unstimulated MDDCs or isotype controls. IL-36α did increase expression of CD40 
above that measured in unstimulated MDDCs or isotype controls (C). FACS
histograms shown are representative of data obtained on 3-5 separate occasions.
Figure 3. IL-36α stimulates IL-12p70 and IL-18 production from MDDCs
IL-12p70 and IL-18 production was compared by ELISA analysis in culture
supernatants from Immature MDDCs (day 5) cultured in media alone or when
cultured in media containing IL-36α (500 ng/ml) for 48h. As an additional control, 
induction of IL-12p70 and IL-18 by IL-36α was also compared to day 5 MDDCs
cultured with IL-36β and IL-1β for 48h. 
(A) Shows a significant increase (P < 0.05) in IL-12p70 production by MDDCs
cultured with IL-36α, IL-36β or IL-1β for 48h compared to unstimulated controls. IL-
36α induced lower IL-12p70 production compared to IL-36β or IL-1β but this was not 
significant. (B) Shows a significant increase (P < 0.05) in IL-18 production by
MDDCs cultured with IL-36α, IL-36β or IL-1β for 48h compared to unstimulated 
controls. IL-36α induced lower IL-18 production compared to IL-36β and 
significantly lower (P < 0.05) IL-18 production when compared to IL-1β. Each data 
point is a mean of 3 replicates performed on 3 separate occasions. Bars show standard
deviation from the mean.
Figure 4. IL-36α-matured MDDCs induce proliferation of (IFN-γ-producing) 
Type1 lymphocytes in allogeneic MDDC/CD3+ lymphocyte cultures
(A) Allogeneic CD3+ lymphocytes were cultured for 5 days with MDDCs matured
with IL-36α, IL-36β or IL-1β for 48h. Proliferation of these lymphocytes was then 
compared to CD3+ lymphocytes cultured without cytokine stimulation or CD3+
lymphocytes stimulated with con A for the same time period. IL-36α-matured 
MDDCs induced > 2 fold increase in CD3+ lymphocyte population and was
comparable to con A but lower than either IL-36β or IL-β (> 3 fold increase). 
(B) A significant increase (P < 0.05) in IFN-γ concentration was measured in culture 
supernatants removed from IL-36α-matured MDDC/CD3+ lymphocytes compared 
with unstimulated CD3+ lymphocytes cultured over the same time period. However,
IL-36α-matured MDDCs stimulated a significantly lower (P < 0.05) IFN-γ 
concentration when compared to either IL-36β or IL-1β-matured MDDCs cultured 
with CD3+ lymphocytes over the same time period. (C) IL-36α, IL-36β or IL-1β-
matured MDDCs stimulated increased concentration of IL-10 in MDDC/CD3+
lymphocyte cultures but this was not significant (P > 0.05). Each data point is a mean
of 3 replicates performed on 3 separate occasions. Bars show standard deviation from
the mean.
Figure 5. IL-36α and IL-36β induces CD14 expression by MDDCs and synergise 
with IFN-γ to produce a CD14high/CD11chigh MDDCs phenotype.
FACS analyses were used to measure expression of CD14 and CD11c on the surface
of MDDCs cultured with IL-1 cytokines (500 ng/ml) and IFN-γ (100 ng/ml) for 48h. 
(A) Isotype controls, IgG2a.PE and IgG1.FITC. (B) = Human monocytes expressing a
characteristic CD14high/CD11clow phenotype. (C) When monocytes were converted to
MDDCs by GMCSF and IL-4 the phenotype shifts to a characteristic
CD14low/CD11chigh. (D) When MDDCs were stimulated with LPS (100 ng/ml) for
48h the phenotype remained CD14low/CD11chigh. However when MDDCs were
stimulated with either (E) IFN-γ, (F) IL-36α or (G) IL-36β for 48h, CD14 expression 
increased and CD11c expression decreased and when MDDCs were co-cultured with
(H) IL-36α and IFN-γ or (I) IL-36β and IFN-γ, CD14 expression increased further and 
CD11c expression returned to the higher levels measured in unstimulated cells.
FACS density plots shown are representative of plots obtained on at least 5 separate
occasions.
Figure 6. IL-36α and IFN-γ synergise to increase the phagocytic capacity and 
iC3b expression in human MDDCs
(A) Showing increased phagocytosis of S. Typhimurium 4/74 was measured after 2h
in 5 day old MDDCs matured with IL-36α (500 ng/ml) for 48h compared with  
Salmonella CFU isolated from unstimulated 7 day old (age matched) MDDCs. A
significant increase (P <0.05) in phagocytosis of Salmonella was measured after 2h in
MDDCs cultured with both IL-36α (500 ng/ml) and IFN-γ (100 ng/ml) for 48h prior 
to exposure to bacteria. Each experiment was performed in quadruplicate on 3
separate occasions, error bars show standard deviation and the large bar shows a
significant difference (P < 0.05) between the CFU isolated from MDDCs cultured
with IL-36α and IFN-γ compared to unstimulated, age matched MDDCs.  (B) IL-36α 
and IFN-γ synergistically increase iC3b interaction with the MDDC membrane above 
that measured when MDDCs are stimulated with either cytokine alone. FACS
histograms show representative plots obtained on 3 separate occasions.
Figure 7. IL-36α- stimulated MDDCs express similar levels of CD1a and CD83 
but lower HLA-DR expression than IFN-γ-stimulated MDDCs  
FACS analyses were also used to measure expression of CD1a, CD83 and HLA-DR
on the surface of human MDDCs cultured with IL-36α (500 ng/ml), IFN-γ (100 
ng/ml) or following co-culture with IL-36α and IFN-γ for 48h. FACS histograms (A) 
show equivalent expression of CD1a following cytokine treatment; (B) shows
identical expression of CD83 following cytokine treatment and (C) shows reduced
expression of HLA-DR following incubation with IL-36α compared to IFN-γ or IL-
36α/IFN-γ co-culture. All plots are representative of data obtained in triplicate on 5 
separate occasions.







